Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020)
Background. Systemic sclerosis (Ssc) is an autoimmune disease characterized by graduate cutaneous and tissue fibrosis development and irreversible fibroproliferative vascular changes.
Saved in:
Main Authors: | Bălănescu Paul (Author), Bălănescu Anca (Author), Bălănescu Eugenia (Author), Băicuş Cristian (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-17 and Th17 cells in systemic sclerosis: a comprehensive review
by: Bălănescu Paul, et al.
Published: (2017) -
Association of Image-Defined Risk Factors with Clinical, Biological Features and Outcome in Neuroblastoma
by: Balanescu Laura, et al.
Published: (2022) -
Immunosuppressive treatment for peripheral neuropathies in Sjogren's syndrome - a systematic review
by: Humă Andreea Camelia, et al.
Published: (2020) -
Hypertriglyceridemia Induced Acute Pancreatitis Caused by a Novel LIPC Gene Variant in a Pediatric Patient
by: Laura Balanescu, et al.
Published: (2022) -
Role of Ultrasonography in the Diagnosis of Wilms' Tumour
by: Radu Ninel Bălănescu, et al.
Published: (2022)